Publicacións nas que colabora con Francisco Javier Rodríguez Berrocal (12)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2020

  1. Value of serum NEUROG1 methylation for the detection of advanced adenomas and colorectal cancer

    Diagnostics, Vol. 10, Núm. 7

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

2017

  1. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

  2. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

    BMC Cancer, Vol. 17, Núm. 1

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  2. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

2010

  1. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

    BMC Cancer, Vol. 10

2009

  1. Soluble CD26 levels and its association to epidemiologic parameters in a sample population

    Disease Markers, Vol. 27, Núm. 6, pp. 311-316

2008

  1. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer

    Anticancer Research, Vol. 28, Núm. 4 C, pp. 2333-2341